Dendritic cells in Leishmania infection

Microbes and Infection

Volumn 6, Issue 15, 2004, Pages 1402-1409

  Brandonisio, Olga ^a,b   Spinelli, Rosa ^a   Pepe, Maria ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Dendritic cells; Leishmania; Leishmaniasis; Vaccine

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 4; LEISHMANIA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELOID DIFFERENTIATION FACTOR 88; OLIGONUCLEOTIDE; PROTOZOAL VACCINE;

CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; DOMESTIC ANIMAL; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOTHERAPY; LEISHMANIASIS; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTOZOON; SHORT SURVEY; T LYMPHOCYTE; VACCINATION; ANIMAL; IMMUNOLOGY; LEISHMANIA MAJOR; PARASITOLOGY; REVIEW; SKIN LEISHMANIASIS;

ANIMALIA; MURINAE; PROTOZOA;

ANIMALS; DENDRITIC CELLS; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; PROTOZOAN VACCINES; VACCINATION;

EID: 16644388726     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.10.004     Document Type: Short Survey

References (65)

1. C. Reis e Sousa, Activation of dendritic cells: translating innate into adaptive immunity, Curr. Opin. Immunol 16 (2004) 21-25.
2. H. Moll, Dendritic cells and host resistance to infection, Cell. Micro-biol 5 (2003) 493-500.
3. M. Sundquist, A. Rydstrom, M.J. Wick, Immunity to Salmonella from a dendritic point of view, Cell, Microbiol 6 (2004) 1-11.
4. T.B. Geijtenbeek, S.J. Van Vliet, A. Engering, B.A. T'Hart, Y. Van Kooyk, Self- and nonself-recognition by C-type lectins on dendritic cells, Annu. Rev. Immunol 22 (2004) 33-54.
5. K. Takeda, S. Akira, TLR signaling pathways, Semin. Immunol 16 (2004) 3-9.
6. J. Colino, C.M. Snapper, Dendritic cells, new tools for vaccination, Microbes Infect 5 (2003) 311-319.
7. K. Shortman, Y.J. Liu, Mouse and human dendritic cell subtypes, Nat. Rev. Immunol 2 (2002) 151-161.
8. D. Otranto, P. Paradies, M. Sasanelli, R. Spinelli, O. Brandonisio, Rapid immunochromatographic test for serodiagnosis of canine leishmaniasis, J. Clin. Microbiol 42 (2004) 2769-2770.
9. L. Fumarola, R. Spinelli, O. Brandonisio, In vitro assays for evaluation of drug activity against Leishmania spp, Res. Microbiol 155 (2004) 224-230.
10. H. Moll, S. Flohé, M. Rollinghoff, Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T-cell immune response, Eur. J. Immunol. 25 (1995) 693-699.
11. T. Baldwin, S. Henri, J. Curtis, M. O'Keeffe, D. Vremec, K. Shortman, E. Handman, Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes, Infect. Immun 72 (2004) 1991-2001.
12. Y. Belkaid, S. Mendez, R. Lira, N. Kadambi, G. Milon, D. Sacks, A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity, J. Immunol. 165 (2000) 969-977.
13. Y. Belkaid, The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection, Expert Opin. Biol. Ther 3 (2003) 875-885.
14. Y. Belkaid, B. Butcher, D.L. Sacks, Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells, Eur. J. Immunol. 28 (1998) 1389-1400.
15. E. Von Stebut, Y. Belkaid, T. Jakob, D.L. Sacks, M.C. Udey, Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity, J. Exp. Med. 188 (1998) 1547-1552.
16. P. Konecny, A.J. Stagg, H. Jebbari, N. English, R.N. Davidson, S.C. Knight, Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12p40 and stimulate primary T-cell proliferation in vitro, Eur. J. Immunol. 29 (1999) 1803-1811.
17. G. Chen, P.A. Darrah, D.M. Mosser, Vaccination against the intracellular pathogens Leishmania major and L. amazonensis by directing CD40 ligand to macrophages, Infect. Immun 69 (2001) 3255-3263.
18. P.M. Gorak, C.R. Engwerda, P.M. Kaye, Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection, Eur. J. Immunol. 28 (1998) 687-695.
19. C.R. Engwerda, P.M. Kaye, Organ-specific immune responses associated with infectious disease, Immunol. Today 21 (2000) 73-78.
20. C.L. Bennett, A. Misslitz, L. Colledge, T. Aebischer, C.C. Blackburn, Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes, Eur. J. Immunol 31 (2001) 876-883.
21. S. Henri, J. Curtis, H. Hochrein, D. Vremec, K. Shortman, E. Handman, Hierarchy of susceptibility of dendritic cell subsets to infection by Leishmania major, inverse relationship to interleukin-12 production, Infect. Immun 70 (2002) 3874-3880.
22. M. Quinones, S.K. Ahuja, P.C. Melby, L. Pate, R.L. Reddick, S.S. Ahuja, Preformed membrane-associated stores of interleukin (IL)-12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite, J. Exp. Med. 192 (2000) 507-516.
23. E. Von Stebut, Y. Belkaid, B.V. Nguyen, M. Gushing, D.L. Sacks, M.C. Udey, Leishmania mojor-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous leishmaniasis, Eur. J. Immunol. 30 (2000) 3498-3506.
24. H. Moll, A. Scharner, E. Kampgen, Increased interleukin 4 (IL-4) receptor expression and IL-4-induced decrease in IL-12 production by langerhans cells infected with Leishmania major, Infect. Immun 70 (2002) 1627-1630.
25. M.L. Mbow, G.K. DeKrey, R.G. Titus, Leishmania major induces differential expression of costimulatory molecules on mouse epidermal cells, Eur. J. Immunol 31 (2001) 1400-1409.
26. F.P. Heinzel, R.M. Rerko, A.M. Hujer, Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity, Cell. Immunol. 184 (1998) 129-142.
27. H. Qi, V. Popov, L. Soong, Leishmania amazonensis-dendutic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo, J. Immunol 167 (2001) 4534-4542.
28. E. Muraille, C. De Trez, B. Pajak, F.A. Torrentera, P. De Baetselier, O. Leo, Y. Carlier, Amastigote load and cell surface phenotype of infected cells from lesions and lymph nodes of susceptible and resistant mice infected with Leishmania major, Infect. Immun 71 (2003) 2704-2715.
29. A.C. Misslitz, K. Bonhagen, D. Harbecke, C. Lippuner, T. Kamradt, T. Aebischer, Two waves of antigen-containing dendritic cells in vivo in experimental Leishmania major infection, Eur. J. Immunol 34 (2004) 715-725.
30. M.A. Campos, I.C. Almeida, O. Takeuchi, S. Akira, E.P. Valente, D.O. Procopio, L.R. Travassos, I.A. Smith, D.T. Golenbock, R.T. Gazzinelli, Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite, J. Immunol 167 (2001) 416-423.
31. T.R. Hawn, A. Ozinsky, D.M. Underhill, ES. Buckner, S. Akira, A. Aderem, Leishmania major activates IL-1 alpha expression in macrophages through a MyD88-dependent pathway, Microbes Infect 4 (2002) 763-771.
32. E. Muraille, C. De Trez, M. Brait, P. De Baetselier, O. Leo, Y. Carlier, Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response, J. Immunol 170 (2003) 4237-4241.
33. M.J. De Veer, J.M. Curtis, T.M. Baldwin, I.A. Di Donato, A. Sexton, M.J. McConville, E. Handman, L. Schofield, MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor-2 signaling, Eur. J. Immunol 33 (2003) 2822-2831.
34. C. De Trez, M. Brait, O. Leo, T. Aebischer, F.A. Torrentera, Y. Carlier, E. Muraille, MyD88-dependent in vivo maturation of splenic dendritic cells induced by Leishmania donovani and other Leishmania species, Infect. Immun 72 (2004) 824-832.
35. M.A. Marovich, M.A. McDowell, E.K. Thomas, T.B. Nutman, IL-12p70 production by Leishmania mojor-harboring human dendritic cells is a CD40/CD40 ligand-dependent process, J. Immunol. 164 (2000) 5858-5865.
36. M.A. McDowell, M. Marovich, R. Lira, M. Braun, D. Sacks, Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent, Infect. Immun 70 (2002) 3994-4001.
37. D. Chaussabel, R.T. Semnani, M.A. McDowell, D. Sacks, A. Sher, T.B. Nutman, Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites, Blood 102 (2003) 672-681.
38. I. Becker, N. Salaiza, M. Aguirre, J. Delgado, N. Carrillo-Carrasco, L.G. Kobeh, A. Ruiz, R. Cervantes, A.P. Torres, N. Cabrera, A. Gonzalez, C. Maldonado, A. Isibasi, Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2, Mol. Biochem. Parasitol 130 (2003) 65-74.
39. H. Jebbari, A.J. Stagg, R.N. Davidson, S.C. Knight, Leishmania major promastigotes inhibit dendritic cell motility in vitro, Infect. Immun 70 (2002) 1023-1026.
40. A. Ponte-Sucre, D. Heise, H. Moll, Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine langerhans cells, Immunology 104 (2001) 462-467.
41. A.P. Vicari, B. Vanbervliet, C. Massacrier, C. Chiodoni, C. Vaure, S. Ait-Yahia, C. Dercamp, F. Matsos, O. Reynard, C. Taverne, P. Merle, M.P. Colombo, A. O'Garra, G. Trinchieri, C. Caux, In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity, Novartis Found. Symp 256 (2004) 241-269.
42. N. Sato, S.K. Ahuja, M. Quinones, V. Kostecki, R.L. Reddick, P.C. Melby, et al., CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania mayor-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation, J. Exp. Med. 192 (2000) 205-218.
43. M.A. Panaro, R. Spinelli, S. Lisi, M. Sisto, A. Acquafredda, L. Fumarola, V. Mitolo, O. Brandonisio, Reduced expression of the chemokine receptor CCR1 in human macrophages and U-937 cells in vitro infected with Leishmania infantum, Clin. Exp. Med 3 (2004) 225-230.
44. M. Ato, S. Stager, C.R. Engwerda, P.M. Kaye, Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis, Nat. Immunol 3 (2002) 1185-1191.
45. C.L. Bennett, L. Colledge, H.E. Richards, P.A. Reay, C.C. Blackburn, T. Aebischer, Uncompromised generation of a specific H-2DM-dependent peptide-MHC class II complex from exogenous antigen in Leishmania mexicana-infected dendritic cells, Eur. J. Immunol 33 (2003) 3504-3513.
46. E. Prina, S.Z. Abdi, M. Lebastard, E. Perret, N. Winter, J.C. Antoine, Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation, J. Cell Sci 117 (Pt 2) (2004) 315-325.
47. J.L. Amprey, G.F. Spath, S.A. Porcelli, Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani, Infect. Immun 72 (2004) 589-592.
48. B.G. Beinhauer, J.M. McBride, P. Graf, E. Pursch, M. Bongers, M. Rogy, U. Korthauer, J.E. de Vries, G. Aversa, T. Jung, Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T-cell hyporesponsiveness in vitro, Eur. J. Immunol 34 (2004) 74-80.
49. Y. Van Kooyk, T.B. Geijtenbeek, DC-SIGN: escape mechanism for pathogens, Nat. Rev. Immunol 3 (2003) 697-709.
50. M. Colmenares, A. Puig-Kroger, O.M. Pello, A.L. Corbi, L. Rivas, Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes, J. Biol. Chem 277 (2002) 36766-36769.
51. B.J. Appelmelk, I. Van Die, S.J. Van Vliet, C.M. Vandenbroucke-Grauls, T.B. Geijtenbeek, Y. Van Kooyk, Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells, J. Immunol 170 (2003) 1635-1639.
52. M. Colmenares, A.L. Corbi, S.J. Turco, L. Rivas, The dendritic cell receptor DC-SIGN discriminates among species and life cycle forms of Leishmania, J. Immunol 172 (2004) 1186-1190.
53. T. Tatsumi, J. Huang, W.E. Gooding, A. Gambotto, P.D. Robbins, N.L. Vujanovic, S.M. Alber, S.C. Watkins, H. Okada, W.J. Storkus, Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity, Cancer Res 63 (2003) 6378-6386.
54. C.G. Figdor, I.J. De Vries, W.J. Lesterhuis, C.J. Melief, Dendritic cell immunotherapy: mapping the way, Nat. Med 10 (2004) 475-480.
55. H. Moll, Dendritic cells as a tool to combat infectious diseases, Immunol. Lett 85 (2003) 153-157.
56. S.B. Flohé, C. Bauer, S. Flohé, H. Moll, Antigen-pulsed epidermal langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major, Eur. J. Immunol. 28 (1998) 3800-3811.
57. S.S. Ahuja, R.L. Reddick, N. Sato, E. Montalbo, V. Kostecki, W. Zhao, et al., Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection, J. Immunol. 163 (1999) 3890-3897.
58. C. Berberich, J.R. Ramirez-Pineda, C. Hambrecht, G. Alber, Y.A. Skeiky, H. Moll, Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens, J. Immunol 170 (2003) 3171-3179.
59. K.J. Stacey, J.M. Blackwell, Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major, Infect. Immun. 67 (1999) 3719-3726.
60. S. Mendez, K. Tabbara, Y. Belkaid, S. Bertholet, D. Verthelyi, D. Klinman, R.A. Seder, D.L. Sacks, Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous leishmaniasis but maintains its potency and durability, Infect. Immun 71 (2003) 5121-5129.
61. I.A. Shah, P.A. Darrah, D.R. Ambrozak, T.N. Turon, S. Mendez, J. Kirman, C.Y. Wu, N. Glaichenhaus, R.A. Seder, Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice, J. Exp. Med 198 (2003) 281-291.
62. J.R. Ramirez-Pineda, A. Frohlich, C. Berberich, H. Moll, Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC, J. Immunol 172 (2004) 6281-6289.
63. M. Ghosh, C. Pal, M. Ray, S. Maitra, L. Mandai, S. Bandyopadhyay, Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis, J. Immunol 170 (2003) 5625-5629.
64. C.L. Van Broekhoven, C.R. Parish, C. Demangel, W.J. Britton, J.G. Altin, Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy, Cancer Res 64 (2004) 4357-4365.
65. A. Cascio, L. Di Martino, P. Occorsio, R. Giacchino, S. Catania, A.R. Gigliotti, C. Aiassa, C. Iaria, S. Giordano, C. Colomba, V.F. Polara, L. Titone, L. Gradoni, M. Gramiccia, S. Antinori, A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience, J. Antimicrob. Chemother 54 (2004) 217-220.